Upadacitinib induction therapy provides steroid-free clinical remission in over 50% of patients with Crohn's disease who do not respond to conventional treatment and has an acceptable safety profile.

Crohn’s disease causes inflammation in the digestive system, mainly in the small intestine and colon. Women are more likely to develop this disease due to excessive hormonal fluctuations compared to ...

One study found that most people are at risk for developing DVT on one out of every 4,656 long flights, which is a relatively ...

Helena Corbett has been called an inspiration by a consultant from Birmingham Women’s and Children’s NHS Foundation Trust ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

There is insufficient evidence to support exclusive enteral nutrition as an adjunctive therapy for active ulcerative colitis, ...

A woman had to learn to walk and talk again after a severe headache turned out to be a stroke. Phoebe O’Shaughnessy, from ...

Patients with Crohn’s disease and spondyloarthritis have a unique composition of enteric bacteria that may differentiate them ...

People with Crohn’s disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, with the bacterium Mediterraneibacter gnavus being a ...

United Digestive's Dr. Aja McCutchen has been awarded the 2025 Rosenthal Award for Volunteer Leadership by the Crohn's & ...

Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...